[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1076 Enrolled Bill (ENR)]
H.R.1076
One Hundred Eighteenth Congress
of the
United States of America
AT THE SECOND SESSION
Begun and held at the City of Washington on Wednesday,
the third day of January, two thousand and twenty-four
An Act
To require the Comptroller General of the United States to carry out a
study on the trafficking into the United States of synthetic drugs, and
related illicit finance, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Preventing the Financing of Illegal
Synthetic Drugs Act''.
SEC. 2. FINDINGS.
The Congress finds the following:
(1) According to the Center for Disease Control and Prevention,
over 107,000 people in the United States died from drug overdoses
or drug poisonings in the 12-month period ending January 2022, with
67 percent of those deaths involving synthetic opioids like
fentanyl.
(2) According to the United National Office of Drugs and Crime
(UNODC) in its ``Synthetic Drug Strategy 2021-2025'', the number of
synthetic drugs, also called New Psychoactive Substances, has
increased 631 percent since 2009, with traffickers introducing an
average of 80 new substances to the illicit drug market each year
from 2009-2019.
(3) In October 2022, F. Michael McDaniel, director of the
Houston High Intensity Drug Trafficking Areas (HITDA) program
testified in Congress that one kilogram of fentanyl can produce one
million counterfeit pills containing one milligram of fentanyl,
saying, ``Currently in Houston, Texas, you can buy a kilogram of
fentanyl for an average price of $25,000 to $30,000. This same
kilogram of fentanyl in Culiacan (Mexico) could be purchased at an
average price of $13,500. Currently, the price of a fentanyl pill
in Houston ranges from $6 to $65. Therefore, an illicit investment
of $30,000 or less could result in a return of $6 to $32.5
million.''.
(4) According to Celina B. Realuyo, Adjunct Professor, The
George Washington University Elliott School of International
Affairs, in March 2022 Congressional testimony, ``Financing is
essential to support and sustain the command and control,
personnel, arms, communications, logistics and operations of
organized crime groups. For this reason, following the money trail
and depriving criminals of illicit financial flows can disrupt and
disable these networks.''.
SEC. 3. GAO STUDY ON SYNTHETIC DRUGS TRAFFICKING.
(a) Study.--The Comptroller General of the United States shall
carry out a study on illicit financing in connection with the
trafficking of synthetic drugs, including fentanyl and methamphetamine,
fentanyl- and methamphetamine-related substances, Captagon, and
fentanyl and methamphetamine precursors, including--
(1) the business of the trafficking of synthetic drugs and
related illicit finance, such as the participation of transnational
criminal organizations and terror syndicates and their notable
trafficking corridors, including source and transit countries;
(2) the business models used by these transnational criminal
organizations, including U.S. domestic and foreign activities for
precursor purchase or production, movement along the supply chain,
manufacture of the completed product, marketing, distribution,
sales, and return of proceeds;
(3) the overlap of the business model of human trafficking and
the trafficking of synthetic drugs and related illicit finance;
(4) the use of online illicit drug markets and the use of
social media for the marketing, sale, and payment for synthetic
drugs;
(5) financial methods used by such transnational criminal
organizations, including--
(A) payment;
(B) money laundering; and
(C) repatriation of proceeds;
(6) the use of social media applications like Snap Chat,
Discord, and Facebook and payment applications like CashApp to
facilitate financial transactions for synthetic drug trafficking,
especially among young people; and
(7) U.S. Government activities to combat illicit finance
related to the trafficking of synthetic drugs, including--
(A) interagency collaboration, including personnel detailed
to other agencies to support the effort to combat synthetic
drugs trafficking and related illicit finance;
(B) intergovernmental collaboration;
(C) intersectoral collaboration with the private sector,
including the business and non-governmental communities; and
(D) identified gaps or resource deficiencies in combating
the trafficking of synthetic drugs and related illicit finance
in the coordination and collaboration activities described in
subparagraphs (A) through (C).
(b) Report Required.--Not later than the end of the 1-year period
beginning on the date of enactment of this Act, the Comptroller General
shall issue a report to the Congress containing all findings and
determinations made in carrying out the study required under subsection
(a).
Speaker of the House of Representatives.
Vice President of the United States and
President of the Senate.